The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Ltd

BSE 544709 · NSE GAUDIUMIVF · ISIN INE0P8B01020 · Group T · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider

₹120.60

+1.99%

BSE close, 28 August 2026

Market cap

₹877.81 cr

7.3 cr shares · Micro cap

Free float

₹251.89 cr

as published

P/E · P/B

— · —

EPS — · BV —

FY25-26 rev / PAT

71.58 / 22.29

₹ cr, as filed

Filings, window

23

8 selected · 35%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹69.50 52-WK HIGH ₹163.70 ₹120.60 54% of range
Against 52-week high-26.3%
Against 52-week low+73.5%
Day change+1.99%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share—
Price / earnings—
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin24.11%
Net margin12.17%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 13.68 1.66 0.23 24.11% 12.17%
Mar-26 · Q 22.17 7.73 1.24 51.60% 34.88%
FY25-26 71.58 22.29 3.59 48.99% 31.14%

Quarter on quarter

Revenue, quarter on quarter
-38.3%
Net profit, quarter on quarter
-78.5%
Operating margin, quarter on quarter
-2,749 bps

Disclosure profile 23 filings in the window

0 median 17.0 p75 · 25 sector max 52 23 72th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

23 filings · 8 selected · busiest 2026-08-13

Filing rhythm · the twelve most recent

2026-08-142026-09-29

SelectedProcedural

Filings

23 in the window · 6 earlier on record

  1. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting Results and Consolidated Scrutinizer's Report of 11th Annual General Meeting of the Company.

    AGM/EGM / AGM View filing →

  2. 28 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceeding of 11th Annual General Meeting of the Company held on Monday, September 28, 2026.

    AGM/EGM / AGM View filing →

  3. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Gaudium IVF and Women Health Limited has informed the Exchange regarding the closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 24 September 2026 ·

    General

    Intimation Under Regulation 30 And Para B, Schedule III - Commencement Of Commercial Operations Of New IVF Centre/Hub At Gurgaon, Haryana

    Intimation regarding commencement of commercial operations at Company's new IVF Centre/Hub at Gurgaon, Haryana

    Company Update / General View filing →

  5. 4 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Intimation of Post Dispatch Newspaper Advertisement for the Notice of 11th Annual General Meeting and E-Voting Information

    Company Update / Newspaper Publication View filing →

  6. 3 September 2026 ·

    General

    Weblink Letter To Shareholders - Pursuant To Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Letter to Shareholders providing the weblink and navigation path for accessing the Annual Report for the Financial Year 2025-26 pursuant to Regulation 36(1)(b) of Listing Regulations.

    Company Update / General View filing →

  7. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report of the Company for the Financial Year 2025-26.

    Others / Reg. 34 (1) Annual Report View filing →

  8. 3 September 2026 ·

    AGM / EGM

    Notice Of 11Th Annual General Meeting Of The Company

    Notice of 11th Annual General Meeting to be held on Monday, September 28, 2026 at 02:00 P.M. (IST) through VC/OAVM

    AGM/EGM / AGM View filing →

  9. 1 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Gaudium IVF and Women Health Limited Informed the exchange about copy of newspaper publication regarding Pre-AGM Notice of 11th Annual General Meeting to be held on Monday, September 28, ....

    Company Update / Newspaper Publication View filing →

  10. 19 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Resullts for the quarter ended June 30, 2026.

    Company Update / Earnings Call Transcript View filing →

  11. 14 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026.

    Company Update / Analyst / Investor Meet View filing →

  12. 14 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

    Company Update / Newspaper Publication View filing →

  13. 14 August 2026 ·

    Investor Presentation

    Investor Presentation

    Revised Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026

    Company Update / Investor Presentation View filing →

  14. 13 August 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026.

    Company Update / Investor Presentation View filing →

  15. 13 August 2026 ·

    Monitoring Agency

    Monitoring Agency Report

    Monitoring Agency Report for the quarter ended June 30, 2026.

    Company Update / Monitoring Agency Report View filing →

  16. 13 August 2026 ·

    Press Release

    Press Release / Media Release

    Press Release on the Unaudited Financial Results of the Compony for the quater ended June 30, 2026.

    Company Update / Press Release / Media Release View filing →

  17. 13 August 2026 ·

    General

    Statement Of Deviation & Variation For The Quarter Ended June 30, 2026

    Intimation of Statement of Deviation & Variation of Funds for the quater ended June 30, 2026

    Company Update / General View filing →

  18. 13 August 2026 ·

    Change in Management

    Change in Management

    Appointment of Secretarial Auditor of the Company for a term of 5 Years, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting of the Company.

    Company Update / Change in Management View filing →

  19. 13 August 2026 ·

    Change in Management

    Change in Management

    Appointment of Internal Auditor of the Company for the Financial Year 2026-27.

    Company Update / Change in Management View filing →

  20. 13 August 2026 ·

    Results

    Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026

    Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026

    Result / Financial Results View filing →

  21. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Meeting Outcome For Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026

    Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  22. 11 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....

    Company Update / Analyst / Investor Meet View filing →

  23. 7 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026.

    Gaudium IVF And Women Health Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Un-audited ....

    Board Meeting / Board Meeting View filing →

RSS feed for Gaudium IVF and Women Health Ltd · the 50 most recent filings